Carole Nuechterlein
CIK 1665133 · last filed 2025-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$58.22M
Companies
4
Total Filings
14
Lifetime Open-Market Net
$6.00M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALGS | Director | 11,025,941 | $5.28 | $58.22M | $6.00M | 8 | 2025-06-26 |
| TRDA | Director | — | $6.46 | — | $0 | 2 | 2022-06-06 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Director | — | $15.90 | — | $0 | 3 | 2020-06-23 |
| AveXis, Inc. (AVXS) Delisted | Director | — | — | — | $0 | 1 | 2016-02-12 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-23 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-21 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-17 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-12 | AveXis, Inc. (AVXS) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.